FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W109389813> ?p ?o ?g. }

• W109389813 endingPage "875" @default.
• W109389813 startingPage "868" @default.
• W109389813 abstract "OBJECTIVE: To define the clinical manifestations, autoantibody associations, optimal treatment, and prognosis of hypergammaglobulinemic purpura associated with systemic autoimmune rheumatic diseases. METHODS: Of 303 consecutive patients with systemic autoimmune rheumatic diseases evaluated over 5 years, 17 French Canadian patients with hypergammaglobulinemic purpura with systemic lupus erythematosus (SLE) (n = 12) or another systemic autoimmune rheumatic disease (n = 5) were identified and followed prospectively. Mild secondary Sjorgren's syndrome developed in 9 (53%) patients. RESULTS: Sixteen (94.1%) patients were women. Attacks of hypergammaglobulinemic purpura occurred in the pretibial (76.5%) or perimalleolar (70.5%) areas or the dorsal aspect of the feet (52.9%). Triggering factors included walking, prolonged standing, and alcohol intake. The mean duration of attacks was 6.1 days. Systemic manifestations consistent with a flare of the underlying systemic autoimmune rheumatic diseases accompanied hypergammaglobulinemic purpura attacks in 15 (88%) patients. Arthralgias (n = 13, 86.6%), arthritis (n = 9, 69.2%), and periarthritis were characterstically localized adjacent to the purpura. Anti-Ro antibodies were expressed in all (100%) patients with hypergammaglobulinemic purpura with SLE, but in only 11 (28.9%) of 38 consecutive patients with SLE without hypergammaglobulinemic purpura (P < 0.000001, odds ratio 84, 95% confidence interval 4.6, 1525). The positive predictive values for hypergammaglobulinemic purpura in SLE were: anti-Ro plus anti-La 73%, anti-La 57%, and anti-Ro 52%. The negative predictive value of anti-Ro was 100%. Although 11 (92%) patients with SLE with anti-Ro expressed anti-52 kDa Ro [4 (36.3%) of whom also expressed anti-60 kDa Ro], this frequency was not greater than in anti-Ro positive patients with SLE without hypergammaglobulinemic purpura. The effects of indomethacin or hydroxychloroquine were assessed over 6 months in 8 patients with recurrent incapacitating hypergammaglobulinemic purpura. Complete (n = 4) or partial (n = 4) remission of hypergammaglobulinemic purpura occurred. In 5 additional patients with severe hypergammaglobulinemic purpura, attacks stopped with prednisone 25 to 60 mg daily. The mean duration of hypergammaglobulinemic purpura followup was 5.4 years (range 1-6 years). At last followup, hypergammaglobulinemic purpura had resolved in 11 (64.7%) patients despite persistently abnormal serology. CONCLUSION: In the absence of anti-Ro antibodies, a presumptive diagnosis of hypergammaglobulinemic purpura secondary to SLE should be questioned. Prednisone should be used only in severe hypergammaglobulinemic purpura. Indomethacin and hydroxychloroquine are of value in the treatment of milder hypergammaglobulinemic purpura." @default.
• W109389813 created "2016-06-24" @default.
• W109389813 creator A5001575821 @default.
• W109389813 creator A5047753466 @default.
• W109389813 creator A5090862999 @default.
• W109389813 date "1995-05-01" @default.
• W109389813 modified "2023-10-18" @default.
• W109389813 title "Hypergammaglobulinemic purpura in systemic autoimmune rheumatic diseases: predictive value of anti-Ro(SSA) and anti-La(SSB) antibodies and treatment with indomethacin and hydroxychloroquine." @default.
• W109389813 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8587074" @default.
• W109389813 hasPublicationYear "1995" @default.
• W109389813 type Work @default.
• W109389813 sameAs 109389813 @default.
• W109389813 citedByCount "4" @default.
• W109389813 countsByYear W1093898132016 @default.
• W109389813 countsByYear W1093898132017 @default.
• W109389813 crossrefType "journal-article" @default.
• W109389813 hasAuthorship W109389813A5001575821 @default.
• W109389813 hasAuthorship W109389813A5047753466 @default.
• W109389813 hasAuthorship W109389813A5090862999 @default.
• W109389813 hasConcept C126322002 @default.
• W109389813 hasConcept C159654299 @default.
• W109389813 hasConcept C16005928 @default.
• W109389813 hasConcept C163764329 @default.
• W109389813 hasConcept C18903297 @default.
• W109389813 hasConcept C198451711 @default.
• W109389813 hasConcept C203014093 @default.
• W109389813 hasConcept C2775915377 @default.
• W109389813 hasConcept C2776670291 @default.
• W109389813 hasConcept C2777077863 @default.
• W109389813 hasConcept C2777121669 @default.
• W109389813 hasConcept C2778674544 @default.
• W109389813 hasConcept C2779075594 @default.
• W109389813 hasConcept C2779123688 @default.
• W109389813 hasConcept C2779134260 @default.
• W109389813 hasConcept C2780648854 @default.
• W109389813 hasConcept C3008058167 @default.
• W109389813 hasConcept C524204448 @default.
• W109389813 hasConcept C71924100 @default.
• W109389813 hasConcept C86803240 @default.
• W109389813 hasConceptScore W109389813C126322002 @default.
• W109389813 hasConceptScore W109389813C159654299 @default.
• W109389813 hasConceptScore W109389813C16005928 @default.
• W109389813 hasConceptScore W109389813C163764329 @default.
• W109389813 hasConceptScore W109389813C18903297 @default.
• W109389813 hasConceptScore W109389813C198451711 @default.
• W109389813 hasConceptScore W109389813C203014093 @default.
• W109389813 hasConceptScore W109389813C2775915377 @default.
• W109389813 hasConceptScore W109389813C2776670291 @default.
• W109389813 hasConceptScore W109389813C2777077863 @default.
• W109389813 hasConceptScore W109389813C2777121669 @default.
• W109389813 hasConceptScore W109389813C2778674544 @default.
• W109389813 hasConceptScore W109389813C2779075594 @default.
• W109389813 hasConceptScore W109389813C2779123688 @default.
• W109389813 hasConceptScore W109389813C2779134260 @default.
• W109389813 hasConceptScore W109389813C2780648854 @default.
• W109389813 hasConceptScore W109389813C3008058167 @default.
• W109389813 hasConceptScore W109389813C524204448 @default.
• W109389813 hasConceptScore W109389813C71924100 @default.
• W109389813 hasConceptScore W109389813C86803240 @default.
• W109389813 hasIssue "5" @default.
• W109389813 hasLocation W1093898131 @default.
• W109389813 hasOpenAccess W109389813 @default.
• W109389813 hasPrimaryLocation W1093898131 @default.
• W109389813 hasRelatedWork W109478897 @default.
• W109389813 hasRelatedWork W142223573 @default.
• W109389813 hasRelatedWork W1560319441 @default.
• W109389813 hasRelatedWork W166462921 @default.
• W109389813 hasRelatedWork W1965793776 @default.
• W109389813 hasRelatedWork W1966963880 @default.
• W109389813 hasRelatedWork W1969678776 @default.
• W109389813 hasRelatedWork W1978169549 @default.
• W109389813 hasRelatedWork W1987412899 @default.
• W109389813 hasRelatedWork W2028949050 @default.
• W109389813 hasRelatedWork W2075415261 @default.
• W109389813 hasRelatedWork W2076010693 @default.
• W109389813 hasRelatedWork W2103305387 @default.
• W109389813 hasRelatedWork W2136764413 @default.
• W109389813 hasRelatedWork W2156355451 @default.
• W109389813 hasRelatedWork W2345231827 @default.
• W109389813 hasRelatedWork W2409242601 @default.
• W109389813 hasRelatedWork W2437161967 @default.
• W109389813 hasRelatedWork W26710338 @default.
• W109389813 hasRelatedWork W39002159 @default.
• W109389813 hasVolume "22" @default.
• W109389813 isParatext "false" @default.
• W109389813 isRetracted "false" @default.
• W109389813 magId "109389813" @default.
• W109389813 workType "article" @default.